Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) Net Margin: 2019-2025

Historic Net Margin for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to -7.53%.

  • Burning Rock Biotech's Net Margin rose 8546.00% to -7.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -13.25%, marking a year-over-year increase of 11294.00%. This contributed to the annual value of -64.92% for FY2024, which is 5582.00% up from last year.
  • As of Q3 2025, Burning Rock Biotech's Net Margin stood at -7.53%, which was up 3.09% from -7.77% recorded in Q2 2025.
  • Burning Rock Biotech's Net Margin's 5-year high stood at -7.53% during Q3 2025, with a 5-year trough of -200.76% in Q2 2022.
  • Moreover, its 3-year median value for Net Margin was -89.12% (2023), whereas its average is -74.55%.
  • Per our database at Business Quant, Burning Rock Biotech's Net Margin plummeted by 9,235bps in 2021 and then soared by 11,164bps in 2023.
  • Burning Rock Biotech's Net Margin (Quarterly) stood at -171.46% in 2021, then slumped by 966bps to -181.12% in 2022, then spiked by 6,445bps to -116.67% in 2023, then soared by 6,225bps to -54.42% in 2024, then soared by 8,546bps to -7.53% in 2025.
  • Its last three reported values are -7.53% in Q3 2025, -7.77% for Q2 2025, and -9.81% during Q1 2025.